NCT04097288View on ClinicalTrials.gov

Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

February 1, 2020

Study Completion Date

May 1, 2020

Conditions

Stress Urinary IncontinenceFecal Incontinence

Interventions

DRUG

Citalopram 40mg

Single dose

DRUG

Reboxetine 8 mg

Single dose

DRUG

Placebo oral tablet

Single dose

DRUG

Placebo oral tablet

Single dose

Trial Locations (1)

2400

Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Copenhagen

All Listed Sponsors

lead

University Hospital Bispebjerg and Frederiksberg

OTHER

NCT04097288 - Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects | Biotech Hunter | Biotech Hunter